Source:http://linkedlifedata.com/resource/pubmed/id/21480626
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2011-5-5
|
pubmed:abstractText |
Members of a series of 2,4,5-substituted pyrimidine derivatives were synthesized, and their interactions with tubulin and their antiproliferative activities against the human hepatocellular carcinoma cells of liver (BEL-7402) were evaluated. One member of this family, the indole-pyrimidine 4k, having an indole-aryl-substituted aminopyrimidine structure, was observed to be an excellent inhibitor of tubulin polymerization (IC(50) = 0.79 ?M) and to display significantly high antiproliferative activities against several cancer cell lines with IC(50) values ranging from 16 to 62 nM. This substance displayed a high propensity to arrests cells at the G(2)/M phase of the cell cycle (EC(50) = 20 nM). In addition, 4k was found to competitively inhibit colchicine binding to tubulin, indicating that it binds to the colchicine-binding site of tubulin. The observations made in this investigation demonstrate that 2,4,5-substituted pyrimidines represent a new class of tubulin polymerization inhibitors with significant antiproliferative activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Colchicine,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Tubulin,
http://linkedlifedata.com/resource/pubmed/chemical/Tubulin Modulators,
http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine,
http://linkedlifedata.com/resource/pubmed/chemical/vinorelbine
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
12
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3200-5
|
pubmed:meshHeading |
pubmed-meshheading:21480626-Binding Sites,
pubmed-meshheading:21480626-Cell Division,
pubmed-meshheading:21480626-Cell Line, Tumor,
pubmed-meshheading:21480626-Colchicine,
pubmed-meshheading:21480626-Drug Screening Assays, Antitumor,
pubmed-meshheading:21480626-G2 Phase,
pubmed-meshheading:21480626-Humans,
pubmed-meshheading:21480626-Indoles,
pubmed-meshheading:21480626-Paclitaxel,
pubmed-meshheading:21480626-Pyrimidines,
pubmed-meshheading:21480626-Structure-Activity Relationship,
pubmed-meshheading:21480626-Tubulin,
pubmed-meshheading:21480626-Tubulin Modulators,
pubmed-meshheading:21480626-Vinblastine
|
pubmed:year |
2011
|
pubmed:articleTitle |
Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.
|
pubmed:affiliation |
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|